Skip to main content
Displaying 265 - 276 of 486
Display:
12
24
48
Liver Tumours
Bayer: Advancements in MRI for imaging assessment of HCC: Practical considerations for differential diagnosis of focal liver ...
Webcasts
View
Liver Tumours
Clinical impact of non-arterial enhancing lesions in patients at risk of HCC - therapy and follow-up
Webcasts
View
Viral Hepatitis
Gilead: Q the Experts on HDV
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk:Clinical harmonisation for improving NASH diagnosis (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Addressing NASH as a chronic metabolic disease: the need for a simplified patient referral pathway
Webcasts
View
Metabolism, Alcohol & Toxicity
Simplifying the patient referral pathway in NASH: expert opinion
Webcasts
View
Metabolism, Alcohol & Toxicity
Discussion and Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and conclusion
Webcasts
View
Viral Hepatitis
GlaxoSmithKline: Nothing about me without me
Webcasts
View
Cirrhosis & Complications
Albumin and the cirrhotic patient journey
Webcasts
View
Cirrhosis & Complications
Stable decompensated cirrhosis and uncomplicated ascites: Biomarkers to personalize albumin treatment
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
…
Page
19
Page
20
Page
21
Page
22
Current page
23
Page
24
Page
25
Page
26
Page
27
…
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy